Inloggad som:
KER-050-D301
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
KER-050-D301
A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept in Adult Participants with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) with Anemia
A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept in Adult Participants with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) with Anemia
PLACEHOLDER
Mer information om studien för vårdgivare
Studien ändrades senast av: studyjohanna (2025-05-18)